Status: Available
Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease
The purpose of this expanded access program is to enable access to R007 (probucol) tablets for the compassionate treatment of adults with mitochondrial disease who also have chronic kidney disease.
Trial details
Age: 18-75Biological sex: AllType: Expanded AccessSponsor: RiboNova Inc.Updated: Apr 17, 2025Locations: 1
Eligibility criteria
Age 18 to 75 years inclusive; [+6]
A known hypersensitivity or adverse reaction to probucol; [+10]